These findings reveal that WDR79 is a novel UHRF1 regulator by maintaining UHRF1 stability, and they also provide a clue as to how to explore WDR79 for potential therapeutic application in NSCLC. The gene discussed is WRAP53; the disease is non-small cell lung carcinoma.